(Q34555301)

3 August 2017

1 reference

title

Report of the task force on designing clinical trials in early (predementia) AD. (English)

1 reference

3 August 2017

6

B Dubois

0 references

Eric Salmon

object named as

E Salmon

15

0 references

Ronald C. Petersen

8

object named as

R C Petersen

1 reference

3 August 2017

P S Aisen

1

1 reference

3 August 2017

S Andrieu

2

1 reference

3 August 2017

C Sampaio

3

1 reference

3 August 2017

M Carrillo

4

1 reference

3 August 2017

Z S Khachaturian

5

1 reference

3 August 2017

H H Feldman

7

1 reference

3 August 2017

E Siemers

9

1 reference

3 August 2017

R S Doody

10

1 reference

3 August 2017

S B Hendrix

11

1 reference

3 August 2017

M Grundman

12

1 reference

3 August 2017

L S Schneider

13

1 reference

3 August 2017

R J Schindler

14

1 reference

3 August 2017

W Z Potter

16

1 reference

3 August 2017

R G Thomas

17

1 reference

3 August 2017

D Salmon

18

1 reference

3 August 2017

M Donohue

19

1 reference

3 August 2017

M M Bednar

20

1 reference

3 August 2017

J Touchon

21

1 reference

3 August 2017

B Vellas

22

1 reference

3 August 2017

language of work or name

English

0 references

publication date

22 December 2010

1 reference

3 August 2017

1 reference

3 August 2017

volume

76

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

280-286

1 reference

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Alzheimer's disease: progress in prediction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Alzheimer's disease therapeutic research: the path forward

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

2009 Alzheimer's disease facts and figures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Recent developments in Alzheimer's disease therapeutics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Methodological issues in primary prevention trials for neurodegenerative dementia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Endpoints for trials in Alzheimer's disease: a European task force consensus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Vitamin E and donepezil for the treatment of mild cognitive impairment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Mild cognitive impairment: clinical characterization and outcome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

The Clinical Dementia Rating (CDR): current version and scoring rules

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Safety and efficacy of galantamine in subjects with mild cognitive impairment

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034393

10.1212/WNL.0B013E318207B1B9

27 October 2018

Identifiers

DOI

1 reference

release_eyqa7i7l7vfjhbmv4g47lqvema

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eyqa7i7l7vfjhbmv4g47lqvema

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3034393

1 reference

3 August 2017

1 reference